Overview Financials News + Filings IR Vault Key Docs Charts Transactions Holdings Ownership Insiders
|
In millions, except per share items | Jun-30-23 | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Pharmaceutical | 190,009.0 | 165,491.0 | 145,796.0 | 137,495.0 | 129,917.0 | 121,241.0 | 116,463.0 | 109,131.0 |
Medical | 15,014.0 | 15,887.0 | 16,687.0 | 15,444.0 | 15,633.0 | 15,581.0 | 13,524.0 | 12,430.0 |
Total revenues | 205,012.0 | 181,364.0 | 162,467.0 | 152,922.0 | 145,534.0 | 136,809.0 | 129,976.0 | 121,546.0 |
Revenue growth [+] | 13.0% | 11.6% | 6.2% | 5.1% | 6.4% | 5.3% | 6.9% | 18.5% |
Pharmaceutical | 14.8% | 13.5% | 6.0% | 5.8% | 7.2% | 4.1% | 6.7% | 19.8% |
Medical | -5.5% | -4.8% | 8.0% | -1.2% | 0.3% | 15.2% | 8.8% | 9.1% |
Cost of goods sold | 198,123.0 | 174,819.0 | 155,689.0 | 146,054.0 | 138,700.0 | 129,628.0 | 123,432.0 | 115,003.0 |
Gross profit | 6,889.0 | 6,545.0 | 6,778.0 | 6,868.0 | 6,834.0 | 7,181.0 | 6,544.0 | 6,543.0 |
Gross margin | 3.4% | 3.6% | 4.2% | 4.5% | 4.7% | 5.2% | 5.0% | 5.4% |
Selling, general and administrative | 4,834.0 | 4,557.0 | 4,533.0 | 4,572.0 | 4,480.0 | 4,596.0 | 3,775.0 | 3,648.0 |
Other operating expenses | 285.0 | 324.0 | 451.0 | 524.0 | 621.0 | 707.0 | 527.0 | 459.0 |
EBITDA [+] | 2,462.0 | 2,356.0 | 2,577.0 | 2,685.0 | 2,733.0 | 2,910.0 | 2,959.0 | 3,077.0 |
EBITDA growth | 4.5% | -8.6% | -4.0% | -1.8% | -6.1% | -1.7% | -3.8% | 16.5% |
EBITDA margin | 1.2% | 1.3% | 1.6% | 1.8% | 1.9% | 2.1% | 2.3% | 2.5% |
Depreciation | 411.0 | 381.0 | 355.0 | 401.0 | 469.0 | 458.0 | 322.0 | 286.0 |
EBITA | 2,051.0 | 1,975.0 | 2,222.0 | 2,284.0 | 2,264.0 | 2,452.0 | 2,637.0 | 2,791.0 |
EBITA margin | 1.0% | 1.1% | 1.4% | 1.5% | 1.6% | 1.8% | 2.0% | 2.3% |
Amortization of intangibles | 281.0 | 311.0 | 428.0 | 512.0 | 531.0 | 574.0 | 395.0 | 355.0 |
EBIT [+] | 1,770.0 | 1,664.0 | 1,794.0 | 1,772.0 | 1,733.0 | 1,878.0 | 2,242.0 | 2,436.0 |
EBIT growth | 6.4% | -7.2% | 1.2% | 2.3% | -7.7% | -16.2% | -8.0% | 11.2% |
EBIT margin | 0.9% | 0.9% | 1.1% | 1.2% | 1.2% | 1.4% | 1.7% | 2.0% |
Non-recurring items [+] | 1,043.0 | 2,260.0 | 1,322.0 | 5,870.0 | -327.0 | 1,752.0 | 122.0 | -23.0 |
Asset impairment | 1,250.0 | 2,050.0 | 79.0 | 7.0 | -488.0 | 1,417.0 | 18.0 | 21.0 |
Legal settlement | -302.0 | 109.0 | 1,129.0 | 5,741.0 | 36.0 | 159.0 | 48.0 | -69.0 |
Interest expense | 93.0 | 149.0 | 180.0 | 238.0 | 294.0 | 329.0 | 201.0 | 178.0 |
Interest expense | 93.0 | 149.0 | 180.0 | 238.0 | 294.0 | 329.0 | 201.0 | 178.0 |
Other income (expense), net [+] | 4.0 | -24.0 | 31.0 | 564.0 | -15.0 | -25.0 | 5.0 | -5.0 |
Gain (loss) on debt retirement | | -10.0 | -14.0 | -16.0 | | -2.0 | | |
Other | 4.0 | -16.0 | 47.0 | 1.0 | -15.0 | -23.0 | 5.0 | -5.0 |
Pre-tax income | 638.0 | -769.0 | 323.0 | -3,772.0 | 1,751.0 | -228.0 | 1,924.0 | 2,276.0 |
Income taxes | 376.0 | 163.0 | -289.0 | -79.0 | 386.0 | -487.0 | 630.0 | 845.0 |
Tax rate | 58.9% | | | 2.1% | 22.0% | 213.6% | 32.7% | 37.1% |
Minority interest | 1.0 | 1.0 | 1.0 | 3.0 | 2.0 | 3.0 | 6.0 | 4.0 |
Net income | 261.0 | -933.0 | 611.0 | -3,696.0 | 1,363.0 | 256.0 | 1,288.0 | 1,427.0 |
Net margin | 0.1% | -0.5% | 0.4% | -2.4% | 0.9% | 0.2% | 1.0% | 1.2% |
|
Basic EPS [+] | $1.00 | ($3.34) | $2.09 | ($12.61) | $4.54 | $0.82 | $4.06 | $4.36 |
Growth | -129.9% | -259.8% | -116.6% | -377.6% | 455.5% | -79.9% | -6.9% | 19.5% |
Diluted EPS [+] | $1.00 | ($3.34) | $2.08 | ($12.61) | $4.53 | $0.81 | $4.03 | $4.32 |
Growth | -129.8% | -260.9% | -116.5% | -378.6% | 457.2% | -79.8% | -6.9% | 19.5% |
|
Dividends per share [+] | $1.98 | $1.96 | $1.94 | $1.92 | $1.91 | $1.85 | $1.80 | $1.55 |
Growth | 1.0% | 1.0% | 1.0% | 0.5% | 3.2% | 2.8% | 16.1% | 11.9% |
|
Shares outstanding (basic) [+] | 261.0 | 279.0 | 292.0 | 293.0 | 300.0 | 313.0 | 317.0 | 327.0 |
Growth | -6.5% | -4.5% | -0.3% | -2.3% | -4.2% | -1.3% | -3.1% | -1.5% |
Shares outstanding (diluted) [+] | 262.0 | 279.0 | 294.0 | 293.0 | 301.0 | 315.0 | 320.0 | 330.0 |
Growth | -6.1% | -5.1% | 0.3% | -2.7% | -4.4% | -1.6% | -3.0% | -1.5% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|